Skip to search.
 FTSE 100 Down 0.28%

Sarepta Therapeutics, Inc. (SRPT)

-NasdaqGS
25.76 Down 0.43(1.64%) 25 Aug 21:00
|After Hours: : 25.51 Down 0.25 (0.97%) 22:54
Prev Close:26.19
Open:26.79
Bid:25.52 x 200
Ask:25.95 x 200
1y Target Est:21.00
Beta:1.76472
Earnings Date:3 Nov - 7 Nov (Est.)
Day's Range:24.96 - 26.98
52wk Range:8.00 - 41.97
Volume:2,028,979
Avg Vol (3m):3,957,340
Market Cap:1.23b
P/E (ttm):N/A
EPS (ttm):-5.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for SRPT at this time.

Comparison

Symbol% ChgMkt Cap
SRPTDown 1.64%1.23b
GSKDown 0.36%106.31b
ALNYDown 2.09%5.94b
ISIS 0.00%6.91b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,001.18
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-5.16
Quarterly EPS Est (Sep-16) :-1.28
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):24.65

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback